Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Arch Pharm Res ; 39(5): 646-59, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26908332

RESUMEN

Ionic liquids (ILs) are defined as salts with a melting point below 100 °C. ILs have received increasing attention as new alternative to organic solvents because of their unique physicochemical properties. Therefore, this study was conducted in the purpose to present the efficacy of ILs as new solvents capable to control the Polymorphic transformation phenomenon. Here, the polymorphic transformation phenomenon of adefovir dipivoxil, an efficient antiviral active pharmaceutical ingredient on human immunodeficiency virus, was investigated. The phase transformation phenomenon from the metastable polymorph, new form (NF) to the stable polymorph, Form-X in 1-allyl-3-ethylimidazolium tetrafluoroborate (AEImBF4) and 1-butyl-2,3-dimethylimidazolium tetrafluoroborate (BDMImBF4) ILs solutions was observed utilizing the solvent-mediated phase transformation method The thermodynamic factors, AEImBF4/BDMImBF4 solvent composition ratio of 3:7-6:4 and the temperature in range of 25-100 °C, as well as the dynamic factor, the rational speed in range of 300-1000 rpm were parameters studied in this experiment. The thermodynamic and dynamic equations involving nucleation and mass transfer were applied for the quantitative analysis. The result of the present study confirmed the use of ILs as substitute solvent for volatile organic solvents, and demonstrated the efficacy of ILs as potential solvent-media to control the polymorphic transformation.


Asunto(s)
Adenina/análogos & derivados , Fármacos Anti-VIH/química , Líquidos Iónicos/química , Organofosfonatos/química , Adenina/química , Cristalización , Estabilidad de Medicamentos , Modelos Teóricos , Transición de Fase , Solubilidad , Soluciones , Espectroscopía Infrarroja por Transformada de Fourier , Temperatura de Transición
2.
Immunopharmacol Immunotoxicol ; 35(1): 126-32, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22889079

RESUMEN

Momordicae Semen, Momordica cochinchinensis Springer (Cucurbitaceae), has long been known to effectively relieve boils, rheumatic pain, and hemorrhoids. In this study, we investigated whether Momordicae Semen extract (MSE) has anti-gastritis effects in various rodent models and also explored possible mechanisms for the gastroprotective effects of MSE. MSE provided remarkable protective effects, comparable to those of rebamipide, in ethanol- and diclofenac-induced acute gastritis. In addition, it has demonstrated protective effect in a Helicobacter pylori-insulted chronic gastritis model. MSE also showed wound healing effect on cutaneous injury of mice and stimulated calcitonin gene-related peptide and somatostatin receptors, which may be related to its anti-gastritis effects. In a single oral dose toxicity study, the approximate lethal dose of MSE was determined at >2000 mg/kg/day. The NOAEL was set to be 2000 mg/kg/day from the repeated oral dose toxicity study. Moreover, momordica saponin I, a major ingredient of MSE, treatment decreased gastric mucosa damage indices in the ethanol- and diclofenac-induced acute gastritis models. The results suggest that MSE could be a promising gastroprotective herbal medicine and momordica saponin I might be used as an active marker compound for MSE.


Asunto(s)
Antiulcerosos/farmacología , Mucosa Gástrica/efectos de los fármacos , Gastritis/tratamiento farmacológico , Momordica/química , Extractos Vegetales/farmacología , Cicatrización de Heridas/efectos de los fármacos , Alanina/análogos & derivados , Alanina/farmacología , Animales , Antiulcerosos/química , Péptido Relacionado con Gen de Calcitonina/metabolismo , Mucosa Gástrica/metabolismo , Gastritis/inducido químicamente , Gastritis/metabolismo , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/metabolismo , Helicobacter pylori/efectos de los fármacos , Helicobacter pylori/metabolismo , Masculino , Ratones , Extractos Vegetales/química , Quinolonas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de Somatostatina/metabolismo , Saponinas/química , Saponinas/farmacología , Semillas/química , Piel/efectos de los fármacos , Piel/metabolismo
3.
Biosci Biotechnol Biochem ; 76(9): 1616-20, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22972321

RESUMEN

A chemical investigation of the n-butanol fraction of the inner bark of Betula platyphylla led to the isolation of seven diarylhepanoids, (-)-centrolobol (1), aceroside VII (2), aceroside VIII (3), (3R)-1,7-bis-(4-hydroxyphenyl)-3-heptanol-3-O-[2,6-bis-O-(ß-D-apiofuranosyl)-ß-D-glucopyranoside (4), 1,7-bis-(4-hydroxyphenyl)-5-hepten-3-one (5), platyphyllone (6) and platyphylloside (7). The antifibrotic effects of these isolates were evaluated with HSC-T6 cells by assessing cell proliferation. Among them, compounds 1, 2, 5 and 6 significantly inhibited the proliferation of HSCs in a dose-dependent manner at concentrations from 10 µM to 100 µM. Compound 5 in particular dramatically decreased the collagen content and increased the Caspase-3/7 activity. Taken together, the antifibrotic activity of B. platyphylla and its constituents might suggest therapeutic potential against liver fibrosis.


Asunto(s)
Betula/química , Diarilheptanoides/farmacología , Células Estrelladas Hepáticas/efectos de los fármacos , Corteza de la Planta/química , Extractos Vegetales/química , Animales , Biomarcadores/metabolismo , Caspasa 3/genética , Caspasa 3/metabolismo , Caspasa 7/genética , Caspasa 7/metabolismo , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Colágeno/genética , Colágeno/metabolismo , Diarilheptanoides/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Expresión Génica/efectos de los fármacos , Células Estrelladas Hepáticas/metabolismo , Células Estrelladas Hepáticas/patología , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática/tratamiento farmacológico , Cirrosis Hepática/metabolismo , Cirrosis Hepática/patología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...